C15.9 C16.9
Conditions
Interventions
Group 1: Hospitalised patients with esophageal- and or gastric cancer.
tests:
- Pulmonary funtion test
- Modified WHO-Test
- One Repetition Maximum Test
- ELISA (3000 µl)
- Force-me
Sponsors
Institut für Kreislaufforschung und Sportmedizin
Abteilung molekulare und zelluläre Sportmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: -All patients with esophageal and or gastric cancer which are hospitalised in the department of general and visceral surgery of the university hospital cologne. -The written consent.
Exclusion criteria
Exclusion criteria: - Patients which are not hospitalised. - Severe COPD (Gold 3+4) - Severe Astma bronchiale - Other severe pulmonary diseases. - Advanced heart failure (NYHA 3+4) - Severe coronary heart disease. - High grade aortic valve stenosis or other high grade cardial valve defects. - AV block 2°+3° or other high grade cardial conduction defects. - High grad Tachykardia - Other high grade cardial underlying diseases. - Severe Hypertonia. - Severe osseous instabilities - Severe neurological or psychological disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring of the physical performance with the modified WHO-Test on a bicycle spiroergometry and comparing the results to an average population. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Pulmonary function via pulmonary function test - Strength via "One Repetition Maximum Test" - Determination of the lactat level from bloodserum - Cytokine patterns via ELISA - Coordination via force-measuring-plate - Cognition via Vienna Test System - Quality of life, fatigue, activity-level via questionnaires | — |
Countries
Germany
Contacts
Public ContactChristoph Baltin
Klinik und Poliklinik für Allgemein, Viszeral und Tumorchirurgie, Universität zu Köln
Outcome results
None listed